* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download A Novel Interacting Protein With The DNA Mismatch Repair Gene
Epitranscriptome wikipedia , lookup
Genetic engineering wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
DNA supercoil wikipedia , lookup
Cell-free fetal DNA wikipedia , lookup
No-SCAR (Scarless Cas9 Assisted Recombineering) Genome Editing wikipedia , lookup
Non-coding DNA wikipedia , lookup
Molecular cloning wikipedia , lookup
Gene expression profiling wikipedia , lookup
Deoxyribozyme wikipedia , lookup
DNA damage theory of aging wikipedia , lookup
Cre-Lox recombination wikipedia , lookup
Microevolution wikipedia , lookup
Epigenomics wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Protein moonlighting wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
Extrachromosomal DNA wikipedia , lookup
Primary transcript wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Oncogenomics wikipedia , lookup
Helitron (biology) wikipedia , lookup
DNA vaccination wikipedia , lookup
Point mutation wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Mir-92 microRNA precursor family wikipedia , lookup
History of genetic engineering wikipedia , lookup
Cancer epigenetics wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
51949 Colorectal Cancer Susceptibility Genes: A Novel Interacting Protein With The DNA Mismatch Repair Gene PMS2 Jonathan Velasquez Mentor: Steven Lipkin DNA mismatch repair (MMR) is associated with hereditary non-polyposis colorectal cancer (HNPCC), the most common known genetic cancer susceptibility syndrome. We are investigating protein interactions between the DNA MMR protein PMS2 and Clone PMS2-Interactor 1 to explain the dominant negative (DN) mechanism of DNA MMR failure. The N-terminus of PMS2 is known to react with other proteins, and expression of the truncated N-terminus of PMS2 exhibits a dominant negative phenotype and microsatellite instability (MSI). Mutated PMS2 does not inhibit initial steps of MMR but interacts with and inhibits a downstream component of the MMR pathway. We hypothesize that the clone construct interacts with and is inhibited by DN-mutated PMS2 resulting in increased levels of MSI and loss of DNA MMR function. We cloned Clone PMS2Interactor 1 through its interaction in the yeast two hybrid cloning assay with the N-terminus of PMS2, and it is known to confer DN-MSI. Our initial study focused on Northern analysis of the 3’ untranslated mRNA of Clone PMS2-Interactor 1, demonstrating wide expression of PMS2Interactor 1 mRNA in mammalian tissues, predominantly in the testes and liver. We also focused on expressing PMS2-Interactor 1 protein in bacteria and the development of reactive antisera for Western analysis. Preliminary data and results show successful expression, and western analysis of the antisera against the construct in bacteria demonstrates reactivity against both GST and PMS2Interactor 1. Our continued investigation using our developed antisera in immuno-precipitation assays and western analysis with different mice tissue will characterize the tissues in which the protein is expressed. Cell cultures with a PMS2-Interactor 1 and green fluorescent binding protein construct will hopefully elucidate PMS2-Intercator 1 localization within cells.